Mario Filion
Gründer bei Alethia Biotherapeutics, Inc.
Profil
Mario Filion is the founder of Alethia Biotherapeutics, Inc., which was founded in 2002.
He currently holds the title of Chief Scientific Officer & Executive VP at the company.
Dr. Filion also held the position of Director-Molecular Genetics at Fortaleza Energy, Inc. and President-Clinical Genomics Division at SignalGene, Inc. In terms of education, Dr. Filion obtained a doctorate degree from the University of Montréal.
Aktive Positionen von Mario Filion
| Unternehmen | Position | Beginn |
|---|---|---|
Alethia Biotherapeutics, Inc.
 Alethia Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Alethia Biotherapeutics, Inc. discovers and develops therapeutic mAbs against highly-disease tissue specific novel clinically-relevant targets. The firm focuses on bone loss in acute disorders, invasive carcinomas and on cancer-associated epithelial-to-mesenchymal transition. The company was founded in 2002 by Mario Filion and Yves Cornellier and is headquartered in Montreal, Canada. | Gründer | 20.07.2009 |
Ehemalige bekannte Positionen von Mario Filion
| Unternehmen | Position | Ende |
|---|---|---|
| FORTALEZA ENERGY INC. | Corporate Officer/Principal | - |
| SignalGene, Inc. | Corporate Officer/Principal | - |
Ausbildung von Mario Filion
| University of Montréal | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 3 |
|---|---|
Fortaleza Energy, Inc.
 Fortaleza Energy, Inc. Oil & Gas ProductionEnergy Minerals Fortaleza Energy, Inc. is an oil and gas company, which engages in the exploration, development, and production of crude oil and natural gas. It also provides custom acid blending services for fracture stimulation and production optimization fluids through its wholly owned subsidiary, BlendForce Energy Services Inc. The company was founded on January 15, 2007 and is headquartered in Calgary, Canada. | Energy Minerals |
Alethia Biotherapeutics, Inc.
Alethia Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Alethia Biotherapeutics, Inc. discovers and develops therapeutic mAbs against highly-disease tissue specific novel clinically-relevant targets. The firm focuses on bone loss in acute disorders, invasive carcinomas and on cancer-associated epithelial-to-mesenchymal transition. The company was founded in 2002 by Mario Filion and Yves Cornellier and is headquartered in Montreal, Canada. | Health Technology |
| SignalGene, Inc. |
